A carregar...
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high fatality. The most urgent need is to find effective treatments. We sought to determine whether hydroxychloroquine (HCQ) application may reduce the death risk of critically ill COVID-19 patients. In this retrospective s...
Na minha lista:
| Publicado no: | Sci China Life Sci |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Science China Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7228868/ https://ncbi.nlm.nih.gov/pubmed/32418114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11427-020-1732-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|